3.0.0 99 2023-01-11T13:20:43Z 2023-01-11T13:20:43Z Senate S S 2011-01-25 112 hssy00 Science, Space, and Technology Committee House Standing hssy20 Energy Subcommittee Referred to 2011-12-02T19:47:19Z Referred to 2011-11-18T18:41:18Z hsif00 Energy and Commerce Committee House Standing hsif03 Energy, Climate and Grid Security Subcommittee Referred to 2011-11-18T19:01:50Z Referred to 2011-11-18T18:41:17Z hsbu00 Budget Committee House Standing Referred to 2011-11-18T18:41:19Z sseg00 Energy and Natural Resources Committee Senate Standing Reported by 2011-05-18T15:01:32Z Markup by 2011-04-12T18:44:14Z Hearings by 2011-02-01T15:06:18Z Referred to 2011-01-25T20:15:22Z S. Rept. 112-17 National Defense Authorization Act for Fiscal Year 2013 112 4310 HR 2013-01-02 Became Public Law No: 112-239. Related bill CRS National Defense Authorization Act for Fiscal Year 2013 112 3254 S 2012-12-12 Pursuant to the provisions of H. Res. 829, papers are returned to the Senate. 17:33:55 Related bill CRS 2011-12-02 hssy20 Energy Subcommittee 1 House committee actions Referred to the Subcommittee on Energy and Environment. Committee 2011-11-18 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Referred to the Subcommittee on Energy and Power. Committee 2011-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsbu00 Budget Committee 2011-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hssy00 Science, Space, and Technology Committee 2011-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2011-11-18 10:04:32 Received in the House. Floor H14000 2 House floor actions 2011-11-18 Senate Message on Senate action sent to the House. Floor 2011-11-17 Senate Passed Senate with an amendment by Unanimous Consent. (text: CR S7780-7782) Floor 2011-11-17 Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text: CR S7780-7782) Floor 17000 9 Library of Congress 2011-11-17 Senate Measure laid before Senate by unanimous consent. (consideration: CR S7778-7782; text of measure as reported in Senate: CR S7778-7780) Floor 2011-05-18 Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 53. Calendars 2011-05-18 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Reported by Senator Bingaman with an amendment in the nature of a substitute. With written report No. 112-17. Committee 2011-05-18 Committee on Energy and Natural Resources. Reported by Senator Bingaman with an amendment in the nature of a substitute. With written report No. 112-17. Committee 14000 9 Library of Congress sseg00 Energy and Natural Resources Committee 2011-04-12 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Ordered to be reported with an amendment in the nature of a substitute favorably. Committee 2011-02-01 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Hearings held. Hearings printed: S.Hrg. 112-4. Committee 2011-01-25 sseg00 Energy and Natural Resources Committee Senate Read twice and referred to the Committee on Energy and Natural Resources. (text of measure as introduced: CR S188-189) IntroReferral 2011-01-25 Sponsor introductory remarks on measure. (CR S188, S189-191) IntroReferral B00100 9 Library of Congress 2011-01-25 Introduced in Senate IntroReferral 10000 9 Library of Congress B000468 Sen. Bingaman, Jeff [D-NM] JESSE BINGAMAN D NM FRANCIS N M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2011-01-25 True H.R.4310 https://www.congress.gov/bill/112th-congress/house-bill/4310 Energy Arms control and nonproliferation Congressional oversight Government studies and investigations Hazardous wastes and toxic substances Health technology, devices, supplies Licensing and registrations Manufacturing Medical tests and diagnostic methods Nuclear power Nuclear weapons Public contracts and procurement Radioactive wastes and releases Trade restrictions Energy 00 2011-01-25 Introduced in Senate 2011-03-24T15:08:04Z American Medical Isotopes Production Act of 2011 - Directs the Secretary of Energy to establish a technology-neutral program to evaluate and support projects for the production in the United States (domestic production), without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, the costs of which shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of the seven-year period for up to another three years if the Secretary makes specified certifications to appropriate congressional committees.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic medical isotope needs; (2) the Secretary certifies to Congress that the export of domestic-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet domestic medical isotope needs during that period; and (3) Congress enacts a joint resolution approving the temporary suspension of such export license restriction.

Requires the NRC Chairman to report to Congress on the current disposition of previous U.S. exports of highly enriched uranium.

Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if specified conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

Directs the Secretary to report to Congress annually for five years on Department of Energy (DOE) actions to support domestic production of molybdenum-99 for medical uses without the use of highly enriched uranium.

Directs the Secretary to arrange with the National Academy of Sciences (NAS) to study the state of molybdenum-99 production and utilization.

]]> 01 2011-05-18 Reported to Senate with amendment(s) 2011-08-31T20:06:40Z American Medical Isotopes Production Act of 2011 - (Sec. 3) Directs the Secretary of Energy (DOE) to establish a technology-neutral program to evaluate and support projects for the production in the United States (except in certain circumstances without the use of highly enriched uranium) of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, whose costs shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005. Authorizes appropriations for FY2011-FY2014.

Directs the Secretary to: (1) develop and update annually a program plan through public workshops; (2) use the Nuclear Science Advisory Committee to conduct annual reviews of progress in achieving program goals; and (3) establish a program to provide assistance for the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium, and for commercial operations using them.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires such contracts to provide for the producers of the molybdenum-99 to take title to and be responsible for the molybdenum-99 created by the irradiation, processing, or purification of uranium leased under this Act.

Requires the contracts to require the Secretary to: (1) retain responsibility for the final disposition of spent nuclear fuel created under this Act for medical isotopes production; and (2) take title to and be responsible for final disposition of radioactive waste created by the irradiation, processing, or purification of uranium leased under this Act for which the producer does not have access to a disposal path.

Requires the producer of the spent nuclear fuel and radioactive waste to characterize accurately, package appropriately, and transport the spent nuclear fuel and radioactive waste before its acceptance by DOE.

Prohibits the Secretary from exchanging uranium for specified services.

Deems radioactive material resulting from the production of medical isotopes that has been permanently removed from a reactor or subcritical assembly, and for which there is no further use, to be low-level radioactive waste if it is acceptable under federal requirements for disposal as low-level radioactive waste.

Authorizes appropriations for the establishment of a program for the final disposition of spent nuclear fuel and radioactive waste for which DOE is responsible.

(Sec. 4) Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of this seven-year period for up to another six years if the Secretary makes specified certifications to certain congressional committees.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic U.S. medical isotope needs, (2) the Secretary certifies to Congress that the export of U.S.-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet U.S. medical isotope needs during that period, and (3) Congress enacts a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 5) Requires the NRC Chairman to report to Congress on the current disposition of previous US exports of highly enriched uranium used as fuel or targets in a nuclear research or test reactor.

(Sec. 6) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, but only if specified conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 7) Directs the Secretary to report to Congress annually for five years on DOE actions to support U.S. production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 8) Instructs the Secretary to arrange with the National Academy of Sciences to study the state of molybdenum-99 production and utilization.

]]> 35 2011-11-17 Passed Senate amended 2012-01-19T22:09:42Z American Medical Isotopes Production Act of 2011 - (Sec. 3) Directs the Secretary of Energy (DOE) to implement a technology-neutral program to evaluate and support projects for the production in the United States (except in certain circumstances without the use of highly enriched uranium) of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, whose costs shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005.

Directs the Secretary to: (1) develop and update annually a program plan through public workshops; (2) use the Nuclear Science Advisory Committee to conduct annual reviews of progress in achieving program goals; and (3) implement a program to provide assistance for the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium, and for commercial operations using them.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires such contracts to provide for the producers of the molybdenum-99 to take title to and be responsible for the molybdenum-99 created by the irradiation, processing, or purification of uranium leased under this Act.

Requires the contracts to require the Secretary to: (1) retain responsibility for the final disposition of spent nuclear fuel created under this Act for medical isotopes production; and (2) take title to and be responsible for final disposition of radioactive waste created by the irradiation, processing, or purification of uranium leased under this Act for which the producer does not have access to a disposal path.

Requires the producer of the spent nuclear fuel and radioactive waste to characterize accurately, package appropriately, and transport the spent nuclear fuel and radioactive waste before its acceptance by DOE.

Prohibits the Secretary from exchanging uranium for specified services.

Deems radioactive material resulting from the production of medical isotopes that has been permanently removed from a reactor or subcritical assembly, and for which there is no further use, to be low-level radioactive waste if it is acceptable under federal requirements for disposal as low-level radioactive waste.

(Sec. 4) Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of this seven-year period for up to another six years if the Secretary makes specified certifications to certain congressional committees.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic U.S. medical isotope needs, (2) the Secretary certifies to Congress that the export of U.S.-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet U.S. medical isotope needs during that period, and (3) Congress enacts a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 5) Requires the NRC Chairman to report to Congress on the current disposition of previous US exports of highly enriched uranium used as fuel or targets in a nuclear research or test reactor.

(Sec. 6) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, but only if specified conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 7) Directs the Secretary to report to Congress annually for five years on DOE actions to support U.S. production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 8) Instructs the Secretary to arrange with the National Academy of Sciences to study the state of molybdenum-99 production and utilization.

(Sec. 9) Repeals the Nuclear Safety Research, Development, and Demonstration Act of 1980.

]]> American Medical Isotopes Production Act of 2011 Display Title American Medical Isotopes Production Act of 2011 Official Title as Introduced A bill to promote the production of molybdenum-99 in the United States for medical isotope production, and to condition and phase out the export of highly enriched uranium for the production of medical isotopes. Introduced in Senate IS Short Titles as Introduced American Medical Isotopes Production Act of 2011 Short Titles as Reported to Senate American Medical Isotopes Production Act of 2011 S Senate Short Titles as Passed Senate American Medical Isotopes Production Act of 2011 S Senate 1223 112 SAMDT To improve the bill. 2022-02-03T06:00:15Z 2011-11-17 Amendment SA 1223 agreed to in Senate by Unanimous Consent. SA 1223 https://www.congress.gov/amendment/112th-congress/senate-amendment/1223 B000468 Sen. Bingaman, Jeff [D-NM] JESSE BINGAMAN D NM FRANCIS 1 1 M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2011-11-17 True 2011-11-17T05:00:00Z 2011-11-17T05:00:00Z Senate 112 S Senate S 99 American Medical Isotopes Production Act of 2011 2023-01-11T13:20:43Z 6 2011-11-17 0 Senate Amendment SA 1223 agreed to in Senate by Unanimous Consent. Floor 2011-11-17 0 Senate Amendment SA 1223 proposed by Senator Levin for Senator Bingaman. (consideration: CR S7780; text: CR S7780) To improve the bill. Floor 2011-11-17 Senate amendment proposed (on the floor): Amendment SA 1223 proposed by Senator Levin for Senator Bingaman.(consideration: CR S7780; text: CR S7780) Floor 93000 9 Library of Congress 2011-11-17 Senate amendment agreed to: Amendment SA 1223 agreed to in Senate by Unanimous Consent. Floor 94000 9 Library of Congress 2011-11-17 Senate amendment submitted Floor 91000 9 Library of Congress Referred in House 2011-11-18T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112s99rfh/xml/BILLS-112s99rfh.xml Engrossed in Senate 2011-11-17T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112s99es/xml/BILLS-112s99es.xml Reported to Senate 2011-05-18T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112s99rs/xml/BILLS-112s99rs.xml Introduced in Senate 2011-01-25T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112s99is/xml/BILLS-112s99is.xml 2011-12-02 Referred to the Subcommittee on Energy and Environment. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.